National Reference Laboratory

What National Reference Laboratory does

National Reference Laboratory (NRL) is a UAE-based clinical laboratory services provider founded in 2010 and headquartered at ICAD 1, Abu Dhabi, operating as a strategic partner of M42 (formed in 2023 via the merger of G42 Healthcare and Mubadala Health). NRL runs a network of 12 state-of-the-art, fully automated laboratories across the UAE and ten Advanced Diagnostics Centres of Excellence covering Anatomic Pathology, Hematopathology, Infectious Diseases, Molecular Diagnostics, Special Chemistry, Special Coagulation, Transplant Immunology, Newborn Screening, Neuro Biochemical Diagnostics, and Wellbeing. It executes more than 10 million diagnostic tests annually (98% in-house) from a menu of 5,000+ tests and holds 28 international accreditations including CAP, ISO 15189, ISO 22870, JCI, and AABB, positioning it as one of the largest CAP-accredited laboratory networks in the region.

NRL's product portfolio spans four service lines: Referral Testing (5,000+ tests ranging from routine to highly specialized including genomics, HLA, newborn screening, oncology, and rare diseases), Laboratory Management (end-to-end onsite lab operation for partner hospitals), Point of Care Testing (POCT programs covering device selection, validation, training, and compliance), and Specialized Testing (including the MENA-first Advanced Alzheimer's blood test). The technology stack includes an advanced Laboratory Information System for real-time test ordering and traceability, NGS and cytogenomics capabilities, AI-powered digital pathology via a partnership with Qritive, and IATA-compliant integrated logistics. The scientific team comprises 25+ board-certified pathologists and clinical scientists supported by 200+ medical laboratory scientists.

NRL monetizes through enterprise B2B contracts: transaction-fee pricing on referral tests, managed-service fees for onsite laboratory operations at hospitals such as Cleveland Clinic Abu Dhabi, Healthpoint, Danat Al Emarat, ICLDC, Mubadala Health Dubai, Fatima bint Mubarak Center, Specialized Rehabilitation Hospital, and Sheikh Sultan Bin Zayed Hospital, plus POCT and corporate occupational-health programs. It serves more than 250 clients across hospitals, clinics, corporations, and other reference laboratories in the UAE and GCC, with dedicated client service operations (800-NRL, cso.nrl.ae portal) and a structured enterprise sales motion. Pricing is not publicly disclosed.

Name

National Reference Laboratory

Legal name

National Reference Laboratory LLC

Website

https://nrl.ae

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

251–500 employees

Short description

National Reference Laboratory is a UAE-based clinical laboratory network operating 12 state-of-the-art facilities under M42, delivering referral testing, onsite laboratory management, point-of-care testing, and specialty diagnostics to 250+ hospitals, clinics, corporations, and reference laboratories across the UAE and GCC.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Reference & Esoteric Testing Laboratories (HLAFAMAJ), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Clinical laboratory services
• Diagnostic testing services
• Laboratory management solutions
• Point-of-care testing
• Genomic diagnostics

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices11 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Referral Testing Services: NRL performs more than 10 million diagnostic tests annually for its clients, with 98% conducted in-house. The growing network serves a wide range of local and regional clients from different market segments. Tests span from routine to highly specialized including genomics, HLA, newborn screening, oncology, and rare diseases.
2. Laboratory Management Services: NRL provides complete onsite laboratory management solutions for healthcare facilities seeking a specialist laboratory operator. Services include laboratory planning, setup, operation, and oversight. Currently managing laboratories across multiple facilities including Specialized Rehabilitation Hospital.
3. Point of Care Testing (POCT) Solutions: End-to-end POCT solutions including device selection, validation, staff training, quality control, and regulatory compliance, supporting healthcare providers in decentralized testing across various clinical settings.
4. Specialized Testing: Advanced diagnostic solutions including the first-in-region advanced Alzheimer's blood test, serving patients and healthcare providers with specialized diagnostic services.
5. Clinical Education Programs: NRL offers clinical education programs including Back-to-Practice Programs for MLTs and Pathologists, Student Internship Programs, and Specialized MLT Training Programs.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

NRL provides clinical laboratory testing, end-to-end laboratory management, and point-of-care testing services across 12 fully automated laboratories in the UAE, serving hospitals, clinics, corporations, and other reference laboratories. Its 5,000+ test menu covers routine diagnostics, genomics, HLA testing, newborn screening, oncology, transplant immunology, and rare diseases, supplemented by 10 Advanced Diagnostics Centres of Excellence and AI-powered specialized diagnostics such as digital pathology for prostate cancer and precision biomarker testing for Alzheimer's disease.

Product overview

National Reference Laboratory operates as a comprehensive diagnostic laboratory network offering a unified platform of clinical testing services. The core portfolio consists of Referral Testing (5,000+ tests covering all disciplines), Laboratory Management (complete onsite solutions), Point of Care Testing (end-to-end POCT), and Specialized Testing (including Advanced Alzheimer's Blood Test). Supporting infrastructure includes ten Advanced Diagnostics Centres (Anatomic Pathology, Hematopathology, Infectious Diseases, Molecular Diagnostics, Special Chemistry, Special Coagulation, Transplant Immunology, Newborn Screening, Neuro Biochemical Diagnostics, and Wellbeing), plus Clinical Education programs. AI-powered capabilities have been added through the Qritive partnership for prostate cancer diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

• Referral Testing Comprehensive laboratory testing services covering more than 5,000 tests across routine diagnostics, genomics, HLA testing, newborn screening, oncology, and rare diseases, serving referring hospitals, clinics, and laboratories across the UAE and GCC region with over 10 million diagnostic tests performed annually.
• Laboratory Management Complete onsite laboratory management solutions for healthcare facilities seeking a specialist laboratory operator, including laboratory planning, setup, operation, and oversight to deliver high-quality patient care while increasing efficiencies and reducing costs.
• Point of Care Testing (POCT) End-to-end POCT solutions supporting healthcare providers in enhancing clinical efficiency and patient care through rapid, accurate diagnostics at the point of service, including device selection, validation, staff training, quality control, and regulatory compliance.
• Specialized Testing Advanced diagnostic solutions including the first advanced Alzheimer's blood test in the UAE and MENA using precision biomarker technology for early detection of neurodegenerative disorders, supporting healthcare providers and patients with specialized diagnostic needs.
• Advanced Diagnostics Centres of Excellence Ten specialized Advanced Diagnostics Centres covering Anatomic Pathology, Hematopathology, Infectious Diseases and Tuberculosis, Molecular Diagnostics and Genomics, Special Chemistry, Special Coagulation, Transplant Immunology, Newborn Screening, Neuro Biochemical Diagnostics (Alzheimer's), and Wellbeing.
• Clinical Education Programs Professional training and internship programs for medical laboratory professionals, including Back-to-Practice Programs for MLTs and Pathologists, Student Internship Programs, and Specialized MLT Training Programs.
• Newborn Screening Comprehensive newborn screening service detecting 43 metabolic, endocrine, hemoglobin, and other disorders relevant to the UAE and region, with confirmatory testing and turnaround times of 24-72 hours.
• AI-Powered Prostate Cancer Diagnostics AI-powered prostate cancer diagnostic solution integrated with Qritive's AI Prostate module that digitally analyses tissue samples, highlights areas of concern, and provides structured insights for faster, more consistent cancer detection and grading aligned with ISUP criteria.

Quantifiable outcome

• NRL performs over 10 million diagnostic tests annually with 98% conducted in-house.
• +5 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature10 records

Partnerships

Twelve partnerships are on record, tiered core, flagship and minor.

• QritivecoreTechnology or Integration · 8 June 2026NRL collaborated with Qritive, a digital pathology innovator, to introduce AI-powered prostate cancer diagnostics in the UAE. Qritive's AI Prostate module is integrated into NRL's diagnostic workflow at Cleveland Clinic Abu Dhabi to support faster, more consistent cancer detection and grading. This partnership addresses rising diagnostic demand and pathology workforce pressures through AI-augmented analysis.
• Neurocode InternationalflagshipStrategic or Co-development Partner · 16 April 2025NRL partnered with Neurocode International to establish the MENA region's first Center for Advanced Neuro Biochemical Diagnostics in Abu Dhabi. The center offers non-invasive Alzheimer's blood testing for patients as young as 40, aiming to reduce Alzheimer's cases in the UAE and wider region. Neurocode provides expertise in neurological diagnostic solutions, with renowned experts including Prof. Henrik Zetterberg and Prof. Kaj Blennow as off-site consultants. The center aims to become the world's most advanced clinical diagnostic laboratory for brain disorders.
• Specialized Rehabilitation Hospital (SRH)coreStrategic or Co-development Partner · 23 November 2021NRL and Specialized Rehabilitation Hospital signed an agreement for NRL to deliver complete laboratory management services for SRH's hospital in Abu Dhabi. This agreement coincided with SRH obtaining JCI accreditation.
• Cleveland Clinic Abu DhabicoreStrategic or Co-development PartnerNRL manages the laboratory operations at Cleveland Clinic Abu Dhabi, providing comprehensive pathology and laboratory medicine services at this flagship facility on Al Maryah Island.
• Mubadala Health DubaicoreStrategic or Co-development PartnerNRL manages laboratory services at Mubadala Health Dubai in Jumeirah, providing comprehensive clinical testing services at this facility.
• HealthpointcoreStrategic or Co-development PartnerNRL manages laboratory services at Healthpoint in Zayed Sports City, Abu Dhabi.
• Danat Al EmaratcoreStrategic or Co-development PartnerNRL manages laboratory services at Danat Al Emarat Hospital in Rabdan, Abu Dhabi. NRL's Executive Director also serves as Chair of Laboratory Services for Danat Al Emarat.
• Imperial College London Diabetes Centre (ICLDC)coreStrategic or Co-development PartnerNRL manages laboratories at both ICLDC Abu Dhabi and ICLDC Al-Ain facilities, supporting specialized diabetes and endocrinology diagnostics.
• Fatima bint Mubarak CentercoreStrategic or Co-development PartnerNRL manages laboratory services at Fatima bint Mubarak Center in the Al Dhafra region of Abu Dhabi.
• Sheikh Sultan Bin Zayed HospitalminorStrategic or Co-development PartnerNRL manages laboratory services at Sheikh Sultan Bin Zayed Hospital in Sharjah.
• M42 (Parent Company)flagshipStrategic or Co-development PartnerNRL is a M42 partner and part of the M42 Group, a global tech-enabled health company based in Abu Dhabi. M42 combines G42 Healthcare's medical and data-centric technologies with Mubadala Health's world-class patient services. NRL benefits from M42's AI, genomics capabilities, and integrated health network including 480+ facilities across 26 countries.
• LabCorpminorStrategic or Co-development PartnerNRL's test menu benefits from the partnership with LabCorp, one of the world's largest laboratory testing companies, which contributed to building one of the largest laboratory test menus globally.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Market position

Competitive moat7 records

Key highlights7 records

Customer concentration

• Xx.com/nrl_uae

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Reference Laboratory